<DOC>
	<DOCNO>NCT00481741</DOCNO>
	<brief_summary>We seek determine use SafeSeal ( TM ) topical hemostasis patch associate reduction time hemostasis time ambulation compare standard manual compression arterial sheath removal follow percutaneous coronary peripheral intervention . We seek assess safety SafeSeal patch compare manual compression .</brief_summary>
	<brief_title>Study SafeSeal ( TM ) Hemostasis Patch Following Percutaneous Coronary Artery Peripheral Vascular Interventions</brief_title>
	<detailed_description>A variety topical hemostasis pad contain procoagulant material currently available accelerate hemostasis removal arterial introducer sheath follow coronary peripheral arterial angioplasty procedure . The effectiveness safety pad , however , remain poorly understood . A total 150 patient undergoing coronary peripheral vascular angioplasty 6 French arterial sheath randomize sheath removal use manual compression alone manual compression combine use SafeSeal ( TM ) hemostasis patch . Sheaths remove activate clotting time ( ACT ) &lt; 250 second , patient keep bedrest 2 hour hemostasis achieve . The primary endpoint time hemostasis . Secondary endpoint witll include time ambulation frequency bleed complication .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>1 . Patient â‰¥ 18 year old 2 . Coronary peripheral vascular intervention 3 . 6 French arterial sheath use 4 . Overnight hospitalization follow procedure 1 . Hematoma persistent bleed around vascular sheath 2 . Previous AV fistula pseudoaneurysm ipsilateral femoral artery 3 . History bleed diathesis coagulopathy 4 . Hemoglobin level &lt; 9 g/dl 5 . Inability ambulate baseline 6 . Known allergy material use SafeSeal 7 . Female patient know pregnant lactate 8 . Evidence ongoing systemic cutaneous infection 9 . Uncontrolled blood pressure follow PCI ( systolic blood pressure &gt; 180 diastolic blood pressure &gt; 110 ) 10 . Current enrolment another ongoing investigational drug/device trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Angioplasty , Percutaneous TransluminalCoronary</keyword>
</DOC>